View Full Technical Datasheet View Full Technical Datasheet Far Infrared Radiation Performance Ollos bioceramic material evaluated by International ASTM E408-13 Standards achieving a mean far infrared emissivity of 0.93. Our proprietary bioceramic technology has been independently tested by the Industrial Technology Research Institute (ITRI) using the internationally recognized ASTM E408-13 standard. Testing confirms our patches achieve an exceptional far infrared emissivity rating of 0.93 β€” among the highest available for therapeutic applications. This remarkable efficiency means our patches convert ambient thermal energy into therapeutic far infrared radiation within the optimal 2-22 ΞΌm wavelength range, precisely matching the frequencies proven most effective for tissue penetration and cellular resonance. Physiological Effects Human subject testing by the Taiwan Textile Research Institute validates a 19.7% increase in local blood flow and 0.7Β°C skin temperature elevation within 20 minutes of patch application. Clinical testing by the Taiwan Textile Research Institute validates Ollos patches' therapeutic efficacy through objective physiological measurements. Within 20 minutes of application, subjects demonstrated a clinically significant 19.7% increase in local blood flow and 0.7Β°C skin temperature elevation. These documented effects confirm enhanced microcirculation and tissue perfusion through advanced thermal imaging and blood flow monitoring. Research & Testing
View Complete Patent & Manufacturing Details Comprehensive Safety Assessment Patent-protected bioceramic technology creates self-activating far infrared emission without external heat sources. Our proprietary manufacturing process represents a significant advancement in far infrared technology, combining specialized materials with controlled thermal processing to create optimal emission properties. Unlike conventional patches that require body heat activation, Ollos patches emit therapeutic radiation at room temperature through a unique crystalline structure protected under U.S. patent filing. This innovation ensures consistent performance across normal ambient conditions while maintaining the highest quality standards through comprehensive testing protocols. View Complete Safety Assessment Comprehensive safety testing by internationally recognized laboratories validates Ollos patches' exceptional safety profile across multiple parameters. Radiation analysis conducted by the Atomic Energy Council detected no measurable radioactive emissions across all naturally occurring isotopes. Concurrent biocompatibility testing under ISO 10993-5 standards demonstrated no cytotoxic effects on mammalian cells, confirming the safety of our materials for therapeutic use. These rigorous assessments ensure our patches meet or exceed medical device safety requirements. Comprehensive Safety Assessment Independent safety testing confirms zero radioactive emissions and non-toxic biocompatibility of Ollos bioceramic materials through radiation analysis and ISO 10993-5 cytotoxicity evaluation.